Hurone AI

📍 Seattle, United States🗓 Founded 2021👥 7 employees💰 Last funded Apr 2024
Software Development🌐 hurone.ai
Website LinkedIn
Hurone AI is accelerating global access to precision cancer care and transforming global oncology through the power of artificial intelligence.  We empower oncologists in care delivery to improve patient outcomes, and provide pharma companies and CROs with real-world data and AI solutions to support clinical trials in other to make cancer data more representative. Our world class team and Board Advisors brings with them extensive experience from institutions like Microsoft, former IBM Watson Health, MIT, Fred Hutch, City of Hope, and have successfully taken tech startups to exit. Beyond our expertise and tenacity to execute, we are collectively driven by our personal and lived experiences that drives us to make a positive impact in the world!
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Hurone AI?
Hurone AI has 1 investors on record on gritt.io, 1 mid-stage.
When did Hurone AI last raise funding?
The most recent investment in Hurone AI recorded on gritt.io was in April 2024.
When was Hurone AI founded?
Hurone AI was founded in 2021.
What industry is Hurone AI in?
Hurone AI operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Hurone AI based?
Hurone AI is headquartered in Seattle, United States.